about
Dietary supplements for dysmenorrhoeaPharmacological interventions for generalised itching (not caused by systemic disease or skin lesions) in pregnancyInterventions for treating constipation in pregnancyInterventions for treating constipation in pregnancyHepatitis B vaccination during pregnancy for preventing infant infectionAntibiotics for meconium-stained amniotic fluid in labour for preventing maternal and neonatal infectionsAntenatal lower genital tract infection screening and treatment programs for preventing preterm deliveryPharmacological interventions for generalised itching (not caused by systemic disease or skin lesions) in pregnancyTerbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomesTerbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomesParacervical local anaesthesia for cervical dilatation and uterine interventionCyclo-oxygenase (COX) inhibitors for preventing preterm labourProgestogens or progestogen-releasing intrauterine systems for uterine fibroidsProgestogens or progestogen-releasing intrauterine systems for uterine fibroidsAntibiotics for meconium-stained amniotic fluid in labour for preventing maternal and neonatal infectionsHepatitis B vaccination during pregnancy for preventing infant infectionVitamin K for the prevention and treatment of osteoporosis in post-menopausal womenHepatitis B vaccination during pregnancy for preventing infant infectionCyclo-oxygenase (COX) inhibitors for preventing preterm labourAntibiotics for meconium-stained amniotic fluid in labour for preventing neonatal sepsisParacervical local anaesthesia for cervical dilatation and uterine interventionAntenatal lower genital tract infection screening and treatment programs for preventing preterm deliveryNonsteroidal anti-inflammatory drugs for primary dysmenorrhoeaMode of delivery and outcomes in preterm births.E2 proteins of high risk human papillomaviruses down-modulate STING and IFN-κ transcription in keratinocytes.Cesarean rates and severe maternal and neonatal outcomes according to the Robson 10-Group Classification System in Khon Kaen Province, Thailand.Correlation of Circulating CD64+/CD163+ Monocyte Ratio and stroma/peri-tumoral CD163+ Monocyte Density with Human Papillomavirus Infected Cervical Lesion Severity.Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia.
P50
Q24186015-11855FC4-7B2F-4A25-ACE8-4EB190B73D7CQ24186119-C973B702-6F4B-42F6-99CD-406ACB09534CQ24187324-4EC69E01-8F3A-446C-B673-D116A75BE05AQ24187557-895AFB32-D180-4115-8A14-A169CDD83CBFQ24188025-4CF92003-EFDB-472E-B1C4-7E13714BDA98Q24188091-418FD368-C049-4F56-95C8-41B3B76D06F8Q24188241-BFA4F767-A389-435A-869E-28494E08A59FQ24193295-3B65587D-A985-4CA2-9994-C84A0BE11BFCQ24197743-6F3351F4-8889-4064-B674-03F6957BFED2Q24197885-9AFF574A-B441-43D6-B674-3C63E1163F4DQ24197982-EB5767FF-93E3-4DB4-929A-780E601A1283Q24198274-626FFC00-9AEE-4A53-A63F-B9DD0BDB67E9Q24200693-5B6F30A3-F654-4823-B0AB-4240DD532CC0Q24234601-6A448548-D61C-418F-8FDF-A9F6E5F33B99Q24235497-70A6B62C-C181-4FC0-A1AB-0BDF35E0E1BFQ24235783-C6EB174B-10E9-4DA8-A429-5EE1E7DB1CFCQ24239937-78FEBC97-E619-480F-9D3B-3C145F429CFBQ24240309-1FA886C4-6256-4FF1-AA6D-FDBD6176F5BBQ24240403-3CB19517-CA73-43D2-BF41-821E764F12D6Q24240413-4438C0CC-D5AB-4077-AE14-3F92423CDFD9Q24241546-5FF87501-0AF0-4499-80C8-A718F25DEA36Q24243200-72C86C65-D4AC-4943-A73B-A881BD0A0D54Q24247742-70C8A39D-7096-4820-AFFE-D132AD733198Q33904420-00605DD3-A52A-40E6-AB91-C70B03963804Q35116264-C2AAB019-5E22-486E-B175-FDF557F0BED9Q47671973-CA313C05-640F-4152-BE0C-2B5DCABD5C0CQ49257819-55DACA21-9BE2-4C6D-B87C-88295563E2EDQ64882434-8CEFB73D-FDE5-4B01-B824-0DCDB452180D
P50
name
Ussanee S Sangkomkamhang
@en
type
label
Ussanee S Sangkomkamhang
@en
prefLabel
Ussanee S Sangkomkamhang
@en